• Redwood AI CEO Louis Dron appeared on Conversations That Matter to discuss British Columbia track-and-trace pilot targeting toxic drug supply.
• Redwood positioned as exclusive AI partner in Aidos-led platform integrating chemistry data with operational intelligence.
• Dron said Redwood analytics aim to convert lab and field data into actionable insights to support faster, more coordinated decisions across agencies.
• Company is developing dashboards to visualize drug-supply trends across time and geography to flag emerging patterns.
• Program, originating from Vancouver General Hospital IMAPP initiative, targets shift from reactive response to earlier intervention.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Redwood AI Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202604291800ACCESSWRNAPR_____1162755) on April 29, 2026, and is solely responsible for the information contained therein.